Evidence map›Paper›PMID 36662072›Full record

ArticleJournal of functional biomaterials2022

Pepper-Mediated Green Synthesis of Selenium and Tellurium Nanoparticles with Antibacterial and Anticancer Potential.

Veer Shah, David Medina-Cruz, Ada Vernet-Crua, Linh B Truong, Eduardo Sotelo, Ebrahim Mostafavi, María Ujué González, José Miguel García-Martín, Jorge L Cholula-Díaz, Thomas J Webster

Open access · goldAbstract read
In one paragraph

Article in Journal of functional biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 6 countries.

Veer ShahDepartment of Chemical Engineering, Northeastern University, Boston, MA 02115, USA.ORCID 0000-0002-6337-9455
David Medina-CruzDepartment of Chemical Engineering, Northeastern University, Boston, MA 02115, USA.
Ada Vernet-CruaDepartment of Chemical Engineering, Northeastern University, Boston, MA 02115, USA.
Linh B TruongDepartment of Chemical Engineering, Northeastern University, Boston, MA 02115, USA.
Eduardo SoteloSchool of Engineering and Sciences, Tecnologico de Monterrey, Monterrey 64849, Mexico.
Ebrahim MostafaviStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.ORCID 0000-0003-3958-5002
María Ujué GonzálezInstituto de Micro y Nanotecnología, IMN-CNM, CSIC (CEI UAM+CSIC), Isaac Newton 8, 28760 Tres Cantos, Spain.ORCID 0000-0001-7012-0049
José Miguel García-MartínInstituto de Micro y Nanotecnología, IMN-CNM, CSIC (CEI UAM+CSIC), Isaac Newton 8, 28760 Tres Cantos, Spain.ORCID 0000-0002-5908-8428
Jorge L Cholula-DíazSchool of Engineering and Sciences, Tecnologico de Monterrey, Monterrey 64849, Mexico.ORCID 0000-0002-4457-1572
Thomas J WebsterSchool of Health Sciences and Biomedical Engineering, Hebei University of Technology, Tianjin 300401, China.ORCID 0000-0002-2028-5969
Northeastern University · USInstitute of Micro and Nanotechnology · ESTecnológico de Monterrey · MXCardiovascular Institute of the South · USHebei University of Technology · CN

Funding

CM SpaceTec, S2018/NMT-4291 TEC2SPACEEuropean Union FEDER, FSEMinistry of Economy, Industry and Competitiveness CSIC13-4E-1794Spanish National Research Council LINKB20024Tecnológico de Monterrey LINKB20024
6 · The paper itself

Abstract

The production of nanoparticles for biomedical applications (namely with antimicrobial and anticancer properties) has been significantly hampered using traditional physicochemical approaches, which often produce nanostructures with poor biocompatibility properties requiring post-synthesis functionalization to implement features that such biomedical applications require. As an alternative, green nanotechnology and the synthesis of environmentally friendly nanomaterials have been gaining attention over the last few decades, using living organisms or biomolecules derived from them, as the main raw materials to produce cost-effective, environmentally friendly, and ready-to-be-used nanomaterials. In this article and building upon previous knowledge, we have designed and implemented the synthesis of selenium and tellurium nanoparticles using extracts from fresh jalapeño and habanero peppers. After characterization, in this study, the nanoparticles were tested for both their antimicrobial and anticancer features against isolates of antibiotic-resistant bacterial strains and skin cancer cell lines, respectively. The nanosystems produced nanoparticles via a fast, eco-friendly, and cost-effective method showing different antimicrobial profiles between elements. While selenium nanoparticles lacked an antimicrobial effect at the concentrations tested, those made of tellurium produced a significant antibacterial effect even at the lowest concentration tested. These effects were correlated when the nanoparticles were tested for their cytocompatibility and anticancer properties. While selenium nanoparticles were biocompatible and had a dose-dependent anticancer effect, tellurium-based nanoparticles lacked such biocompatibility while exerting a powerful anti-cancer effect. Further, this study demonstrated a suitable mechanism of action for killing bacteria and cancer cells involving reactive oxygen species (ROS) generation. In summary, this study introduces a new green nanomedicine synthesis approach to create novel selenium and tellurium nanoparticles with attractive properties for numerous biomedical applications.

Indexed as

antibacterialanticancerbiomedicinechalcogensnanoparticlespeppers

Identifiers

PMID36662072
PMCPMC9867025
OpenAlexW4313392058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.